When Stephanie de Garay allowed her three children to sign up for Pfizer’s COVID-19 shot trial, she assumed the worst that could happen was anaphylactic shock — and in that case, they’d be treated with an EpiPen and be fine. From her daughter’s perspective, the trial was a way to keep up with a close… Read More »
In a news release quietly published June 29, 2022, the U.S. Department of Health and Human Services announced that it, in partnership with the Department of Defense, agreed to purchase another 105 million doses of Pfizer’s COVID-19 shot — for $ 3.2 billion.1 The contract is intended to supply shots for a coming fall injection… Read More »
As the U.S. Food and Drug Administration continues to release Pfizer’s clinical trial documentation,1 we’re finding more and more evidence that very little has been done on the up-and-up, and the COVID jab trials may be among the most fraudulent in medical history. Can All Serious Adverse Effects Be Written Off? Importantly, Pfizer classified almost… Read More »
In November 2021, Brook Jackson, a whistleblower who worked on Pfizer’s Phase 3 COVID jab trial in the fall of 2020, warned she’d seen evidence of fraud in the trial. Data were falsified, patients were unblinded, the company hired poorly trained people to administer the injections, and follow-up on reported side effects lagged way behind.… Read More »
Pfizer and BioNTech said Monday that their coronavirus vaccine, already authorized for those 12 and older, has been shown to be safe and effective in young children ages 5 to 11, which potentially provides a pathway toward inoculating the vast majority of U.S. schoolchildren against COVID-19. Ofer Levy, professor of pediatrics at Harvard Medical School… Read More »
[unable to retrieve full-text content]FRIDAY, Sept. 17, 2021 — An advisory panel to the U.S. Food and Drug Administration on Friday recommended a third Pfizer-BioNTech COVID vaccine booster shot for all Americans aged 65 or older, as well as for those deemed to be at high risk for… Drugs.com – Daily MedNews